Inactive Instrument

Other languages Maxpro Capital Acquisition Corp. Nasdaq

Equities

Maxpro Capital Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23
Apollomics, Inc. completed the acquisition of Maxpro Capital Acquisition Corp. from MP One Investment LLC and others in a reverse merger.	28/03/23
Apollomics Gets Orphan Drug Designation for Vebreltinib to Treat Lung Cancer	15/11/22
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	02/11/22
Apollomics to be Listed on Nasdaq Through Business Combination With Maxpro Capital Acquisition	14/09/22
Maxpro Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22
Maxpro Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22

No results for this search